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Phosphoglycerate kinase (PGK) functions as a cytoplasmic ATP-generating glycolytic enzyme, a nuclear mediator in DNA replication
and repair, a stimulator of Sendai virus transcription and an extracellular disulfide reductase in angiogenesis. Probing of a developmental
expression library from Dictyostelium discoideum with radiolabelled calmodulin led to the isolation of a cDNA encoding a putative
calmodulin-binding protein (DdPGK) with 68% sequence similarity to human PGK. Dictyostelium, rabbit and yeast PGKs bound to
calmodulin-agarose in a calcium-dependent manner while DdPGK constructs lacking the calmodulin-binding domain (209KPFLAILG-
GAKVSDKIKLIE228) failed to bind. The calmodulin-binding domain shows 80% identity between diverse organisms and is situated
beside the hinge and within the ATP binding domain adjacent to nine mutations associated with PGK deficiency. Calmodulin addition
inhibits yeast PGK activity in vitro while the calmodulin antagonist W-7 abrogates this inhibition. Together, these data suggest that PGK
activity may be negatively regulated by calcium and calmodulin signalling in eukaryotic cells.
D 2004 Elsevier B.V. All rights reserved.
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Phosphoglycerate kinase (ATP: 3-phospho-d-glycerate
1-phosphotransferase, EC 2.7.2.3; PGK) is a ubiquitous
monomeric enzyme that has been isolated from diverse
species ranging from humans and plants to bacteria [1].
PGK is an ATP-generating glycolytic enzyme that forms
part of the glycolytic, gluconeogenic and photosynthetic
pathways [2,3]. PGK is secreted by tumour cells where it
acts as a disulfide reductase to stimulate the release of the
tumour blood vessel inhibitor angiostatin [4]. In the
mammalian nucleus, PGK influences DNA replication
and repair and it has been identified as a host factor
necessary for in vitro mRNA synthesis of the Sendai virus0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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USA.[5,6]. Mutations in PGK have been linked to haemolytic
anaemia and mental retardation [7]. PGK is also a target
for drug design for diseases caused by anaerobic parasites,
such as trypanosomes and Clonorchis spp. [8]. Thus
understanding how PGK is regulated has many biomedical
implications.
Calmodulin (CaM) is a sensor of intracellular calcium
fluxes that functions by binding to and regulating CaM-
binding proteins (CaMBPs) [9]. In addition to its other
intracellular functions, CaM controls metabolism through
the regulation of glycolysis and mitochondrial oxidative
metabolism [10,11]. For example, mammalian phospho-
fructokinase, the rate-limiting enzyme of glycolysis, is a
calmodulin-binding protein [12]. Unlike most protein–
protein interactions, there is no specific targeting domain
that mediates calmodulin-binding to its CaMBPs. Classi-
cally, calcium-dependent CaM-binding involves domains
of ~20 amino acids that possess motifs defined by the
location of bulky hydrophobic residues in relation to basic
residues with aromatic amino acids in flanking positions
[13,14]. In contrast, calcium-independent binding is
considered to primarily occur through IQ motifsta 1693 (2004) 177–183
Fig. 1. Alignment of Dictyostelium (DdPGK) with human PGK (humPGK). Identical residues are highlighted in black; similar in gray; (=) 12 domains that
comprise the substrate binding cleft with percentage of identity shown above; (+) hinge.
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endotoxin and the calcium-activated potassium channel
suggest that new modes of binding are yet to be
discovered [16].
Profiling with the calmodulin-binding overlay techni-
que (CaMBOT) has identified dozens of CaMBPs specific
to certain sub-cellular locales, behavioural and devel-
opmental events [17–20]. CaMBOT probing of cDNAFig. 2. Structure of Dictyostelium PGK (DdPGK). (A) Diagrammatic representatio
(B) The CaMBD of DdPGK fits both the 1–5–10 and 1–14 motifs common to oth
the DdPGK CaMBD.expression libraries has been used to isolate numerous
novel CaMBPs from a number of species [21–23]. In
Dictyostelium, CaMBOT probing of a developmental
cDNA library has led to the isolation of numerous
CaMBPs including nucleomorphin, an acidic, nuclear
CaMBP that regulates the number of nuclei produced
by these eukaryotic cells [21]. As we detail here, another
cDNA isolated from this Dictyostelium expression libraryn showing conserved PGK regions plus the CaMBD identified in this study.
er Ca2+-dependent CaMBPs some of which are shown. (C) Helical wheel of
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phosphoglycerate kinase (DdPGK). DdPGK was found
to be very similar to other eukaryotic PGKs and it, along
with PGK from yeast and rabbit, was shown to contain a
highly conserved putative CaM-binding domain and to
bind to CaM in a calcium-dependent manner. CaM was
also shown to inhibit yeast PGK activity. These data
suggest that PGK may be regulated by calcium–CaM-
mediated signal transduction.Fig. 3. The CaMBD and ability to bind CaM are highly conserved. (A)
Clustal alignment of the predicted CaM-binding domain indicating
conserved hydrophobic residues of 1–5–10 and 1–14 motifs. Identical
(black), homologous (gray) and substrate interaction residues (*) are
indicated. (B) In vitro binding of Dictyostelium, rabbit and yeast PGKs to
CaM. rDdPGK or purified rabbit and yeast PGKs were incubated with
CaM-agarose beads in the presence of 5 mM Ca2+, 10 mM EGTA or 60
AM W-7. Bound CaMBPs were resolved on 15% SDS-PAGE. MW marker
positions (kDa) are on the left. Input: SDS-PAGE of total extract. (*) Inset
Positive control: Recombinant Dictyostelium T7tag-calcineurin A.2. Materials and methods
Unless otherwise specified, the following sources were
used: restriction enzymes (Amersham Pharmacia); T4
DNA ligase (New England Bio Labs); culture media
(BioShop Canada; VWR Scientific Products); low DNA
mass ladders (Gibco-BRL); PCR MW markers and
protease inhibitor cocktail (Boehringer Mannheim); PCR
primers and Qiaex II Gel Extraction system (Qiagen).
2.1. CaMBOT screening of a kZAP cDNA expression
library
Titration of bacteriophage and screening of the cDNA
library were essentially carried out as described [25].
Variations in protocol were implemented with respect to
the use of 35S-radiolabelled recombinant CaM as a probe.
Screening, sequencing and sequence analysis was per-
formed exactly as described previously [24].
2.2. Polymerase chain reaction amplification of DdPGK
The cDNA encoding the entire open reading frame for
DdPGK was amplified by the PCR. The forward primer
designated pPGK-f incorporates a unique restriction site for
SacI (5V-AAAGAGCTCAATGTCTTCAAATAAAATTGG-
TAATAAATTAAGTCCT-3V). The reverse primer desig-
nated pPGK-r incorporates a unique restriction site for the
restriction enzyme XhoI (5V-TATAATTTATTCTCGA-
GAATTCATAATCAGATAAAGCAG-3V). A single 1287-
bp PCR product was amplified. Deletion constructs were
amplified essentially as described above using the following
primer and PCR conditions. DdPGKDN43—Primers were
designed to amplify the region encoding amino acids 44
through 420. SacI and XhoI restriction sites were added to
the 5V- and 3V-ends, respectively, using the primers
pPGKmutA (5V-ATTGATGCATCGAGCTCAACATTAG-
AATATTGTTTAAAG-3V) and pPGK-r. DdPGKDN205—
Primers were designed to amplify the region encoding
amino acids 206 through 420. SacI and XhoI restriction sites
were added to the 5V- and 3V-ends, respectively, using the
primers pPGKmutB (5V-TCACCATCAAAGAGCTC-
CTTGGCAATTCTTGGCGGTGC-3V) and pPGK-r.
DdPGKDN257—Primers were designed to amplify the
region encoding amino acids 258 through 420. SacI andXhoI restriction sites were added to the 5V- and 3V-ends,
respectively, using the primers pPGKmutC (5V-TCAT-
CATTGTTGAGCTCAACAGCCGAACAAATCACCAAA
G-3V) and pPGK-r. DdPGKDN228—Primers were designed
to amplify the region encoding amino acids 229 through
420. SacI and XhoI restriction sites were added to the 5V-
and 3V-ends, respectively, using the primers pPGK mutE (5V-
AAAATTAAACTGAGCTCAAACCTTTTGTA -
TAAAGTCGATGAAATGATCATTGG-3V) and pPGK-r.
DdPGKDC159 (N43)—Primers were designed to amplify
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XhoI restriction sites were added to the 5V- and 3V-ends,
respectively, using the primers pPGKmutA and pPGKmutD-r
(5V-TTCGGCTGTCTCGAGTTACAATGATGAAC-
CAATCTCTTTG-3V).
2.3. Construction and expression of pET-21b (+) DdPGK
vectors
The amplified DdPGK cDNA sequences were digested
using the restriction enzymes SacI and XhoI and then ligated
into the vector pET-21b (+) (Novagen) as per the manufac-
turer’s recommendations. Plasmids were screened for an
insert using the restriction enzymes SacI and XhoI,
sequenced and then designated pDdPGK, pDdPGKDN43,
pDdPGKDN205, pDdPGKDN228, pDdPGKDN257 and
pDdPGKDC159 (N43), respectively. The induction and
expression of each plasmid was carried out essentially as
described with minor modifications using the E. coli strain
BL21 (Novagen).
2.4. SDS-PAGE and Western blotting analysis of pDdPGK
After protein dye assay (BioRad), 10 Ag volumes of
uninduced and induced protein samples were loaded onto
15% SDS-PAGE and electrophoresis and subsequent
Western blotting were carried out as detailed previously
[24].Fig. 4. Localization of the CaM-binding region of DdPGK. (A) Schematic r
[(+)=binding; ()=no binding]. T7-epitope tag at its amino terminus (speckled) an
mutants. See Fig. 2 for details.2.5. Pull-down assay with CaM-agarose beads
The pull-down CaM-binding assay was performed using
calmodulin-agarose beads (Sigma-Aldrich) as detailed
previously [24]. The samples containing bound protein
were then detected by Western blotting.
2.6. Enzymatic assay of PGK
The in vitro activity of PGK was measured based on
the forward reaction (1,3-bisphosphoglycerate+ADPY3-
phosphoglycerate+ATP) using continuous spectrophoto-
metric rate determination assay method (Sigma Technical
Bulletin SPGLYC100 [25]. The enzyme solutions con-
sisted of PGK (Baker’s yeast 3-phosphoglyceric phospho-
kinase) that had been pre-incubated for 5 min in 50 mM
potassium phosphate (PGK; untreated) or in 50 mM
potassium phosphate in the presence of 1 mM CaM plus
5 mM CaCl2 (CaM; treated) or 1 mM CaM plus 5 mM
CaCl2 in the presence of 60 AM W-7 (W-7; treated). The
assay solution also was allowed to equilibrate for 1 min
prior to the addition of 0.03 units of the untreated or
treated enzyme solutions. A blank with no enzyme was
also run and subtracted as background for the calculation
of the amount of inhibition. The change in absorbance at
340 nm at 258C was measured every 5 s for the first half-
minute and then every 30 s through 4 min for each
treatment. Each treatment was performed six independentepresentations of deletion mutants. CaM-binding is shown on the right
d CaM-binding domain (gray box) are shown. (B) CaM-binding of deletion
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plotted over time. An analysis of covariance (ANCOVA)
for each data point was done using the Systatk software
package (Version 10.2).Fig. 5. (A) Enzymatic activity of yeast PGK. Blank (open triangles, solid
line), yeast PGK (open squares, solid line), yeast PGK+1 mM CaM
(closed squares, dotted line) and yeast PGK+1 mM CaM+60 AM W-7
(closed triangles, dotted line). Results are the meanFS.D. (perpendicular
bars mostly fall within symbol area) of six independent determinations.
(B) Time course of CaM inhibition of PGK activity. (C) Position (*) of
nine mapped PGK mutations associated with hereditary haemolytic
anaemia [7,32]. *From left to right: 157GNV; 163DNV; 190 or 191 K
del; 205RNP; 251ENA; 252INT; 265VNM; 267DNN; 285DNV.3. Results and discussion
3.1. Dictyostelium PGK
We used CaMBOT with 35S-VU1-CaM to isolate
cDNAs encoding putative CaMBPs from a developmental
cDNA expression library of Dictyostelium discoideum
[21]. After stringent screening, three were found to be
similar to human PGK-1 displaying 68% sequence
identity and 78% homology [26,27]. A single open
reading frame encoded a 420 aa protein (45.7 kDa).
Previous studies have shown that about 15% of PGK
residues are conserved among all species [1]. Of the
remaining residues, 30% show conservative changes,
likely due to their importance in maintaining the tertiary
structure while 55% of residues are not conserved.
DdPGK showed the same domains common to other
eukaryotic PGKs with a highly conserved hinge
(FAKALE) among other defining attributes (Figs. 1, and
2A) [2,27–29]. For example, DdPGK showed 69%
sequence identity with the nucleotide (ADP/ATP) binding
region (residues 190–404) of human PGK. As detailed in
Fig. 1, the DdPGK sequence shared very high sequence
identity with the full complement of 12 domains that
comprise the substrate binding cleft.
3.2. PGK is a calmodulin-binding protein
Evidence that PGK is a Ca2+-dependent CaMBP comes
from several sources. First, CaMBOT has been used
widely to isolate cDNAs encoding proteins that have
subsequently been verified as true CaMBPs [20]. Analysis
of the DdPGK sequence using The Calmodulin Target
Database indicated binding sites of which a single
presumptive CaMBD was resolved (Fig. 2A) [14].
Continuous CaMBDs of Ca2+-dependent CaMBPs fit a
select number of motifs [13,30]. The putative CaMBD of
DdPGK (209KPFLAILGGAKVSDKIKLIE228) fits both 1–
5–10 and 1–14 motifs, each of which is common to
several other known Ca2+-dependent CaMBPs (Fig. 2B).
Helical wheel analysis shows the a-helical distribution of
hydrophobic and basic charged residues (Fig. 2C).
A comparison of the DdPGK CaMBD with the same
region in various species revealed that this region is highly
conserved (80% identity) in hamsters, humans, chickens,
flies, mice, rats, worms and yeast (Fig. 3A). This domain
contains 1–5–10 and 1–14 CaM-binding motifs both of
which are 100% conserved suggesting the fundamental
importance of this sequence. The ability of PGK to bind to
calmodulin was then assessed.Recombinant DdPGK (rDdPGK) resolved at the same
size as rabbit muscle PGK and yeast PGK on SDS-PAGE
(Fig. 3B,C). To verify the association of DdPGK with
CaM in vitro, bacterial cell lysates containing expressed
rDdPGK were incubated with CaM-agarose in the
presence of Ca2+ or EGTA, a calcium chelator. rDdPGK
was retained on CaM-agarose in the presence of Ca2+ but
not in the presence of EGTA (Fig. 3B). The potent CaM
inhibitor W-7 abolished binding of rDdPGK to CaM (Fig.
3B). Both rabbit muscle PGK and yeast PGK were also
retained on CaM-agarose in the presence of Ca2+ but not
in the presence of EGTA (Fig. 3C). The CaM-binding of
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phosphatase 2B, from Dictyostelium (DdCN) served as a
control (Fig. 3C, inset) [9]. Thus the PGKs from
Dictyostelium, rabbits and yeast are Ca2+ -dependent
calmodulin-binding proteins. These findings suggest that
interaction of CaM with PGK is a specific property
conserved across species.
3.3. The CaM-binding domain is highly conserved
To verify the region responsible for CaM-binding, we
generated a series of deletion mutants lacking increasing
amounts of amino-terminal or carboxyl-terminal residues
that encroached on the putative CaMBD (Fig. 4A). Of
the six deletion constructs tested, all were retained on
CaM-agarose in the presence of Ca2+ except for
DdPGKDN228 and DdPGKDN257 (Fig. 3B). Therefore,
DdPGK interacts with CaM through amino acids between
Lys209 and Glu228 corresponding to the central domain of
PGK adjacent the hinge and within the nucleotide-binding
domain (Figs. 1 and 2A). Notably, a comparison of the
full DdPGK CaM-binding region with that of human
PGK shows 90% sequence identity including 100%
identity for the appropriate hydrophobic residues plus
the conservation of nucleotide-interacting residues Gly217
Ala218 Lys219 Lys223, which are a common attribute of
PGK. This evidence and the presence of the experimen-
tally determined CaM-binding domain adjacent to the
hinge suggest that CaM could play a role in regulating
PGK activity.
3.4. Calmodulin inhibits PGK activity
To test this, PGK activity was measured in the
presence of CaM and the CaM inhibitor W-7 [32]. Initial
attempts to assay enzymatic activity of rDdPGK expressed
and purified from the E. coli strain BL21 (DE3) yielded
inconsistent activities. Since this might have been due to
improper posttranslational modifications or folding of the
enzyme in the bacterial expression host, biochemically
purified yeast PGK was used. Yeast PGK enzyme activity
showed a steady, highly reproducible increase over 60 s
as seen in Fig. 5A, an activity that remained linear for up
4 min after which it levelled off (data not shown). The
activity of yeast PGK was significantly (ANCOVA,
P=0.01) inhibited by 1 mM Ca2+-CaM at all times over
the assay period (Fig. 5A,B). In contrast, when PGK
activity was measured in the presence of CaM plus the
potent CaM inhibitor W-7, there was no significant effect
on PGK activity (Fig. 5A). Plotting the activity of CaM-
inhibited PGK as a percentage of untreated PGK activity
revealed that CaM caused an immediate 100% inhibition
of PGK activity that decreased over the next 20 s of the
reaction before stabilizing at approximately 40% inhibition
(range 36–45% inhibition; Fig. 5B). This stable level of
inhibition continued for at least 4 min (40.0% inhibitionat 240 s). The temporal dynamics of this inhibitory
response supports the idea that PGK could be negatively
regulated in some cells by Ca2+/CaM-mediated signal
transduction.
These results not only place PGK in the realm of
enzymes regulated by Ca2+/CaM-mediated signalling,
they also have implications for other research. Approx-
imately four-dozen families have been reported with a
hereditary deficiency of PGK often presenting with
central nervous system dysfunction and/or myopathy
[7,31,32]. Currently, 14 mutations causing structural
abnormalities have been elucidated, nine of which fall
adjacent to the CaMBD identified here (Fig. 5C). These
mutations could affect calmodulin binding and thus
interfere with normal calcium/calmodulin-mediated regu-
lation of PGK activity.Acknowledgements
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